Mark Stroick
Impact in
- Physiology top 2%
- Alzheimer's disease research and treatments
- Biological Psychiatry top 10%
Papers in
-
- Protease and Inhibitor Mechanisms 5
-
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Thomas Bertsch (4 shared papers)Klaus von Bergmann (4 shared papers)Klaus Faßbender (4 shared papers)Dieter Lütjohann (3 shared papers)Sandra Kühl (2 shared papers)Mikael Simons (1 shared paper)Konrad Beyreuther (1 shared paper)Patrick Keller (1 shared paper)
- Journals
- Cerebrovascular Diseases (5 papers)Stroke (2 papers)Ultrasound in Medicine & Biology (2 papers)Metabolism (1 paper)Thrombosis Research (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Mark Stroick
18 papers receiving 1.6k citations
Mark Stroick's Hit Papers
Peers
Comparison fields: 5 of 86
- Physiology 660
- Biological Psychiatry 34
- Surgery 495
- Neurology 89
- Computational Theory and Mathematics 182
Countries citing papers authored by Mark Stroick
This map shows the geographic impact of Mark Stroick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stroick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stroick more than expected).
Fields of papers citing papers by Mark Stroick
This network shows the impact of papers produced by Mark Stroick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stroick. The network helps show where Mark Stroick may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stroick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo Hit paper breakdown → | 2001 | 923 |
| 2 | 2004 | 110 | |
| 3 | 2002 | 102 | |
| 4 | 2007 | 96 | |
| 5 | 2009 | 53 | |
| 6 | 2005 | 52 | |
| 7 | 2006 | 38 | |
| 8 | 2008 | 35 | |
| 9 | 2007 | 31 | |
| 10 | 2006 | 28 | |
| 11 | 2008 | 26 | |
| 12 | 2008 | 25 | |
| 13 | 2009 | 24 | |
| 14 | 2006 | 23 | |
| 15 | 2008 | 22 | |
| 16 | 2016 | 10 | |
| 17 | 2002 | 7 | |
| 18 | 2012 | 7 |
About Mark Stroick
Mark Stroick is a scholar working on Cancer Research, Molecular Biology, Biomedical Engineering, Surgery and Neurology, having authored 18 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Ultrasound and Hyperthermia Applications (5 papers), Cholesterol and Lipid Metabolism (4 papers), Alzheimer's disease research and treatments (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers) and Photoacoustic and Ultrasonic Imaging (2 papers). The work is most often cited by research in Physiology (660 citations), Biological Psychiatry (34 citations), Surgery (495 citations), Neurology (89 citations) and Computational Theory and Mathematics (182 citations). Mark Stroick has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Thomas Bertsch, Klaus von Bergmann, Klaus Faßbender, Dieter Lütjohann, Sandra Kühl, Mikael Simons, Konrad Beyreuther, Patrick Keller, Heiko Runz and Christine Bergmann. Their work appears in journals such as Cerebrovascular Diseases, Stroke, Ultrasound in Medicine & Biology, Metabolism and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.